THE MAIN ASPECTS OF MENOPAUSAL METABOLIC SYNDROME
DOI:
https://doi.org/10.61841/83t6dx62Keywords:
perimenopause, postmenopause,, late reproductive period,, ,climacteric syndrome, atherogenic inde, Kupperman index.Abstract
ObjectiveThe aim of the study was to conduct a comprehensive assessment of women's health in the late reproductive, peri- and postmenopausal periods to determine the frequency, clinical course, as well as the prerequisites for the development of climacteric syndrome (CS) and metabolic syndrome (MS). We can state that the main triggers are hyperinsulinemia, insulin resistance and visceral obesity, which contribute to dyslipidemia, oxidative stress, inflammation, altered coagulation and atherosclerosis observed during menopause. Timely undetected and untreated metabolic disorders can adversely affect the duration and quality of life of women.
Materials and methods:Examination of 1484 women aged 35-70 and conducting general clinical, special gynecological, biochemical (lipid spectrum with calculation of the atherogenic index of plasma, glucose level in blood serum), as well as conducting an assessment scale of Kupperman menopausal index for the presence of CS with determination of its severity, as well as determination MS frequencies.
Results:It was determined that CS was observed in 93.3% of the examined women against a background of aggravated somatic and gynecological pathology. This led to the development of menopausal syndrome in 30.6% of women, and most often it was observed in perimenopausal women (45-54 years old) - in 33.9% and almost every second woman (55.4%) with moderate grade CS gravity. Conclusion:The presence of MS indicators significantly aggravates the course of menopause, causing high comorbidity and the development of the clinic of CS.
Downloads
References
[1] Tsu VD, Jeronimo J, Anderson BO. Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ. 2013;91(9):683-690. doi:10.2471/blt.12.116020
[2] Stachowiak G, Pertyński T, Pertyńska-Marczewska M. Metabolic disorders in menopause. Prz Menopauzalny. 2015;14(1):59-64. doi:10.5114/pm.2015.50000
[3] Chen YC, Tsao LI, Huang CH, Yu YY, Liu IL, Jou HJ. An Internet-based health management platform may effectively reduce the risk factors of metabolic syndrome among career women. Taiwan J Obstet Gynecol. 2013;52(2):215-221. doi:10.1016/j.tjog.2013.04.011
[4] Ciucurel C, Iconaru EI. Association between metabolic syndrome and depression in elderly. Procedia - Soc Behav Sci. 2012;33:994-997. doi:10.1016/j.sbspro.2012.01.271
[5] Heindel JJ, Blumberg B, Cave M, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3-33. doi:10.1016/j.reprotox.2016.10.001
[6] Arai H, Yamamoto A, Matsuzawa Y, et al. Prevalence of the metabolic syndrome in elderly and middle-aged Japanese. J Clin Gerontol Geriatr. 2010;1(2):42-47. doi:10.1016/j.jcgg.2010.10.011
[7] Bertoia ML, Allison MA, Manson JE, et al. Risk factors for sudden cardiac death in post-menopausal women. J Am Coll Cardiol. 2012;60(25):2674-2682. doi:10.1016/j.jacc.2012.09.031
[8] Wong RHX, Evans HM, Howe PRC. Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal women. Alzheimer’s Dement Transl Res Clin Interv. 2016;2(3):162-168. doi:10.1016/j.trci.2016.07.003
[9] Gustafsson PE, Hammarström A. Socioeconomic disadvantage in adolescent women and metabolic syndrome in mid-adulthood: An examination of pathways of embodiment in the Northern Swedish Cohort. Soc Sci Med. 2012;74(10):1630-1638. doi:10.1016/j.socscimed.2012.01.044
[10] Schultz AB, Edington DW. Analysis of the association between metabolic syndrome and disease in a workplace population over time. Value Heal. 2010;13(2):258-264. doi:10.1111/j.1524-4733.2009.00651.x
[11] DeFilipp Z, Duarte RF, Snowden J a., et al. 27184625. Biol Blood Marrow Transplant. 2016;22(8):1493-1503. doi:10.1016/j.bbmt.2016.05.007
[12] El Habachi NM, Maklad HM, Sharara GM, Allam EA, Fawzy EM. A comparative study between the effect of 17-β estradiol and antioxidants combination on some menopausal changes in oophorectomised rats. Middle East Fertil Soc J. 2014;19(4):303-313. doi:10.1016/j.mefs.2014.02.003
[13] Kim JH, Meyers MS, Khuder SS, et al. Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice. Mol Metab. 2014;3(2):177-190. doi:10.1016/j.molmet.2013.12.009
[14] Lin YH, Chang HT, Tseng YH, et al. Characteristics and health behavior of newly developed metabolic syndrome among community-dwelling elderly in Taiwan. Int J Gerontol. 2013;7(2):90-96. doi:10.1016/j.ijge.2012.07.003
[15] Kok HS, van Asselt KM, van der Schouw YT, et al. Heart Disease Risk Determines Menopausal Age Rather Than the Reverse. J Am Coll Cardiol. 2006;47(10):1976-1983. doi:10.1016/j.jacc.2005.12.066
[16] Martins M do C, Lima Faleiro L, Fonseca A. Relationship between leptin and body mass and metabolic syndrome in an adult population. Rev Port Cardiol (English Ed. 2012;31(11):711-719. doi:10.1016/j.repce.2012.09.008
[17] Richards M, Black S, Mishra G, Gale CR, Deary IJ, Batty DG. IQ in childhood and the metabolic syndrome in middle age: Extended follow-up of the 1946 British Birth Cohort Study. Intelligence. 2009;37(6):567-572. doi:10.1016/j.intell.2008.09.004
[18] Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic Role of Flow-Mediated Dilation and Cardiac Risk Factors in Post-Menopausal Women. J Am Coll Cardiol. 2008;51(10):997-1002. doi:10.1016/j.jacc.2007.11.044
[19] Nishio E, Hayashi T, Nakatani M, et al. Lack of association of ovariectomy-induced obesity with overeating and the reduction of physical activities. Biochem Biophys Reports. 2019;20(July):100671. doi:10.1016/j.bbrep.2019.100671
[20] Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-1132. doi:10.1016/j.jacc.2010.05.034
[21] Miller VM, Lahr BD, Bailey KR, Hodis HN, Mulvagh SL, Jayachandran M. Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women. Atherosclerosis. 2016;246:21-28. doi:10.1016/j.atherosclerosis.2015.12.030
[22] Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of mediterranean diet on metabolic syndrome and its components: A meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011;57(11):1299-1313. doi:10.1016/j.jacc.2010.09.073
[23] Jou HJ, Hsu IP, Huang HT, et al. A Hospital-Based Therapeutic Lifestyle Program for Women With Metabolic Syndrome. Taiwan J Obstet Gynecol. 2010;49(4):432-437. doi:10.1016/S1028-4559(10)60094-0
[24] Shapovalov, V.V., Gurevich, B.S., Dudnikov, S.Y., Belyaev, A.V., Zagorsky, I.G.Optical non-invasive methods for glucose determination in human blood(2018) International Journal of Pharmaceutical Research, 10 (1), pp. 324-
329.https://www.scopus.com/inward/record.uri?eid=2s2.085057062870&partnerID=40&md5=066604f29ec4fa1 6e76049c6383d038a
[25] Beula Princy, S., & Dr. Duraisamy, S. (2016). Analysis of Retinal Images Using Detection of the Blood Vessels by Optic Disc and Optic Cup Segmentation Method. International Scientific Journal on Science Engineering & Technology, 19(2), 33-40.
[26] Kumaresan, D.C., & Dr. Selvan, P. (2016). A Survey on Two Port DC-DC Converter Topologies for Energy Preservation, International Scientific Journal on Science Engineering & Technology, 19 (4), 66-73.
[27] Perez-Alvarez, F., Timoneda-Gallart, C., Mayoral-Rodríguez, S. Performance of 2146 children ages 5 to 15 with learning and behavioral dysfunction on the Das Naglieri Cognitive assessment system (2019) NeuroQuantology, 17 (1), pp. 59-71.
[28] Liu, C., Xu, Z., Chen, Y., Zhu, T., Wang, R. A zebrafish behavior assay for assessing anti-epileptic drug efficacy (2019) NeuroQuantology, 17 (1), pp. 1-9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
